Elimination of anticardiolipin antibodies and cessation of cognitive decline in a UV-A1-irradiated systemic lupus erythematosus patient

Lupus

Volumn 14, Issue 10, 2005, Pages 859-861

  McGrath Jr , Hugh ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Anticardiolipin antibodies; Neuropsychiatric; Singlet oxygen; Systemic lupus erythematosus; Ultraviolet A1

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADULT; ARTICLE; CASE REPORT; COGNITIVE DEFECT; FEMALE; HUMAN; LIVEDO RETICULARIS; POSITRON; PRIORITY JOURNAL; RADIATION DOSE; REVISED SYSTEMIC LUPUS ACTIVITY MEASURE SCORE; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET A RADIATION;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; COGNITION DISORDERS; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; POSITRON-EMISSION TOMOGRAPHY; ULTRAVIOLET THERAPY;

EID: 27744462579     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2164cr     Document Type: Article

References (18)

1. McGrath H Jr, Martinez-Osuna P, Lee FA. Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus. Lupus 1996; 5: 269-274.
2. Molina JF, McGrath H Jr. Long term ultraviolet-A-1 irradiation therapy in systemic lupus erythematosus. J Rheumatol 1997; 24: 1072-1074.
3. Menon Y, McCarthy K, McGrath H Jr. Reversal of brain dysfunction with UV-A1 irradiation in a patient with systemic lupus. Lupus 2003; 12: 479-482.
4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 1997; 40: 1725.
5. Otte A, Weiner SM, Peter HH et al. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur J Nucl Med 1997; 24: 787-791.
6. Sebastiani GD, Galeazzi M, Tincani A et al. Anticardiolipin and antibeta2GP1 antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. Scand J Rheumatol 1999; 28: 344-351.
7. Lockshin MD. Antiphospholipid syndrome. In Harris ED Jr, Budd RC, Firestein GS et al. eds. Kelley's textbook of rheumatology, Philadelphia: Elsever Sanders, 2005: 1248-1257.
8. Out HU, De Groot PG, Hasselaar P, Van Vliet M, Derksen RHWM. Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 1989; 48: 1023-1028.
9. Alarcon-Segovia D, Deleze M, Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989; 68: 353-365.
10. Polderman MCA, le Cessie S, Huizinga TWJ et al. Efficacy of UV-A1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology 2004; 43: 1402-1404.
11. Svensson BO. Serum factors causing impaired macrophage function in systemic lupus erythematosus. Scand J Immunol 1975; 5: 145-150.
12. Hermann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1241-1250.
13. Sorice M, Circella A, Misasi R et al. Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipid antibodies. Clin Exp Immunol 2000; 122: 277-284.
14. Cohen PL, Caricchio R, Abraham V et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002; 196: 135-140.
15. Manfredi AA, Rovere P, Galati G et al. Apoptotic cell clearance in systemic lupus erythematosus. Opsonization by antiphospholipid antibodies. Arthritis Rheum 1998; 41: 205-214.
16. Tyrrell RM. Role for singlet oxygen in biological effects of ultraviolet A radiation. Methods Enzymol 2000; 319: 290-296.
17. Yamamoto N, Homma S, Sery TW, Donoso LA, Hoober JK. Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells in haematoporphyrin derivative and light. Eur J Cancer 1991; 27: 467-471.
18. Okayasu T, Curtis MT, Farber JL. Structural alterations of the inner mitochondrial membrane in ischemic liver cell injury. Arch Biochem, Biophys 1985; 236: 638-645.